Green tea is one of the few natural interventions for fibroids with genuine clinical trial data. Here is what it shows, what it does not, and how to use it practically.
The Active Compound: EGCG
Epigallocatechin gallate (EGCG) is the key polyphenol in green tea with anti-inflammatory, anti-proliferative, and antioxidant properties. Fibroid-relevant research uses concentrated EGCG rather than standard brewed tea.
The Clinical Trial
A randomised, double-blind, placebo-controlled trial (Roshdy et al., 2013) gave women with symptomatic fibroids 800mg of green tea extract daily (45% EGCG) or placebo for four months. The EGCG group showed approximately 32.6% reduction in total fibroid volume, significantly reduced symptom severity, and improved quality of life. The placebo group showed a small increase in fibroid volume.
Limitations and Practical Dose
This is one trial — replication is needed. The dose (800mg EGCG/day) exceeds what standard green tea provides (50–100mg per cup). A standardised EGCG supplement at 400–800mg/day is the practical route to the studied dose. Matcha provides a more concentrated beverage option. Combined with anti-inflammatory diet and other evidence-based supplements, the compounding effect is meaningful.
